J Wafflart

CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study

Jean‐Marc Riedinger, J Wafflart, Gabriel Ricolleau et al. · Annals of Oncology · 2006 · 101 citations · Full text

Ca 125, Medicine, Cancer Management +8

pS2 protein: a marker improving prediction of response to neoadjuvant tamoxifen in post-menopausal breast cancer patients

Isabelle Soubeyran, Nathalie Quénel, Jean‐Michel Coindre et al. · British Journal of Cancer · 1996 · 69 citations · Full text

Prognostic Biomarkers, Neoadjuvant Tamoxifen, Breast Oncology +8

Change in CA 125 levels after the first cycle of induction chemotherapy is an independent predictor of epithelial ovarian tumour outcome

J.-M. Riedinger, Franck Bonnetain, J.P. Basuyau et al. · Annals of Oncology · 2007 · 39 citations · Full text

Ca 125, Medicine, Independent Predictor +9

Quantitative determination of c-erbB-2 in human breast tumours: potential prognostic significance of low values

Serge Koscielny, P. Terrier, A Daver et al. · European Journal of Cancer · 1998 · 26 citations

Tumor Biology, Human Breast Tumours, Breast Oncology +12

Adjuvant trial for stage II receptor-positive breast cancer: CMF vs. CMF+ tamoxifen in a single centre

L. Mauriac, M. Durand, J Chauvergne et al. · Breast Cancer Research and Treatment · 1988 · 21 citations

Breast Oncology, Oncology, Adjuvant Trial +7